Inception Fertility at ASRM 2022 Conference

See our family of brands at the premier conference for reproductive medicine

The ASRM Scientific Congress & Expo, held in Anaheim, California, October 22-26, brings together top fertility professionals from around the world. Inception is proud of our own industry leaders, who have contributed research and technology that’s helping to shape the future of patient-centered care.

2022 Inception and Family of Brands Engagement

PRESENTATIONS

 

  • P-216 IMPACT OF COVID-19 VACCINATION ON ART OUTCOME Presenting Author – Poster (Entry id #14801)
    Monday, October 24, 2022: 6:30 AM – 7:30 AM, ACC, Poster Hall in Expo Hall
  • Abstract Title: 14797: IMPACT OF COVID-19 VACCINATION ON ART OUTCOME IN THE CONTEXT OF MALE PATIENTS Oral
    Session Title: Oral Abstract Session: Environment and Reproduction Presentation Time: 11:15 AM
  • Session title: Oral Abstract Session: ART Lab 1
    Monday, October 24, 2022: 10:45 AM – 12:15 PM, ACC, 213CD
  • 11:15 AM COMPETENCY AND BENCHMARK VALUES FOR VIENNA CONSENSUS ART LABORATORY KEY PERFORMANCE INDICATORS (KPIs) REDEFINED: REAL-WORLD DATA FROM 80 NORTH AMERICAN IVF LABORATORIES
    Jason KM Au, MSc
    , Sung Ta Tsou, B.SC., May Tian, MSc and Jon C Havelock, MD, FRCSC, DABOG, Pacific Centre for Reproductive Medicine, Burnaby, BC, Canada
    · Anaheim Convention Center – 213CD
  • POSTGRADUATE COURSE
    Saturday October 22, 1-5 PM
    PG05 – PG05: An Evidence-Based Integrative Approach to Fertility and Preconception Care Ashley M Eskew, Audrey Jane Gaskins, ScD, Alice D Domar, Ph.D.
  • ROUNDTABLE
    Monday October 24, 12:20 PM
    RTM08 – Methods to Reduce Infertility Treatment Discontinuation Due to the Emotional Burden of Care Alice D Domar, Ph.D., Inception, Houston, TX
  • ORAL ABSTRACT, PRIZE PAPER SESSION
    Tuesday October 25, 10:45 AM
    0-92 – The Impact of an Adapted Spikes Protocol versus Standard of Care in Delivering Negative Pregnancy Test Results to IVF Patients: A Multicenter, Randomized Controlled Trial Domar AD, Kordikadis A, Bortoletto P, Gulragiani N, Khodakhah D, Rooney KL, Gompers AD, Hacker MR, Grill EA
  • ORAL ABSTRACT
    Tuesday October 25, 11:00 am
    0-160 – Embryologist Burnout: Physical and Psychological Symptoms and Occupational Challenges Currently Reported by U.S. Embryologists
    Murphy A, Baltimore H, Lapczynski MS, Proctor G, Meyer EC, Gylnn T, Domar AD, Collins MG
  • ANDRIA ROUND TABLES
    Differences in Genetic Carrier Screenings (CS) Panels Necessitate Intended Parent (IP) Education for Gamete Donor Selection
    Spectrum of Embryo Mosiacism Detected by Preimplantation Genetic Testing for Aneuploidy (PGT-A) Determines Reproductive Outcome
    Impact of Discrepant Variant Classification on Preimplantation Genetic Testing for Monogenic Conditions (PGT-M)

    TECHNICAL PUBLICATIONS

    • ICING ON THE CAKE: CAN OOCYTES “ON ICE” RESULT IN MORE THAN ONE LIVE BIRTH (LB)?
      Cascante SD, Blakemore JK, Parra CM, DeVore S, Hodes-Wertz B, McCaffrey C, Grifo JA
      Accepted: Poster
    • DON’T DIVIDE THE DOSE: ONCE DAILY (QD) AND TWICE DAILY (BID) EARLY CYCLE GONADOTROPIN (GND) DOSING HAVE EQUIVALENT ASSISTED REPRODUCTIVE TECHNOLOGY (ART) OUTCOMES – A QUALITY IMPROVEMENT (QI) PROJECT.
      Cascante SD, Shaw J, Licciardi F, Fino ME, Grifo JA, Blakemore JK
      Accepted: Oral
    • A RESILIENT WOMB: MATERNAL AGE AT TRANSFER FOLLOWING AUTOLOGOUS OOCYTE (AO) CRYOPRESERVATION (CRYO) DOES NOT IMPACT ONGOING PREGNANCY + LIVE BIRTH RATES (LBRS).
      Barrett F, Cascante SD, McCulloh DM, Grifo JA, Blakemore JK
      Accepted: Oral
    • CUMULATIVE LIVE BIRTH RATES (CLBRS) FROM FROZEN AUTOLOGOUS OOCYTES (AOS): LARGEST COHORT OF PLANNED OOCYTE CRYOPRESERVATION (OC) THAWS FROM A SINGLE CENTER IN THE UNITED STATES
      DeVore S, McCulloh DM, Grifo JA
      Accepted: Poster
    • TO CANCEL OR NOT TO CANCEL: LIVE BIRTH RATES (LBRS) IN IN VITRO FERTILIZATION (IVF) CYCLES WITH FIVE OR FEWER FOLLICLES
      Bayefsky MJ, Cascante SD, McCulloh DM, Blakemore JK
      Accepted: Poster
    • A QUALITY IMPROVEMENT PATHWAY (QIP) FOR FERTILITY CARE (FC) IN GENERAL OBSTETRICS AND GYNECOLOGY (GYN) CLINIC AT NEW YORK CITY (NYC)’S LARGEST PUBLIC HOSPITAL
      Parra CM, Shaw J, Cascante SD, DeVore S, Blakemore JK
      Accepted: Poster
    • ARE PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A) OUTCOMES DIFFERENT IN INFERTILE (INF) AND FERTILE (FT) PATIENTS (PTS)?
      Auran E, Dahiya A, Cascante SD, Blakemore JK
      Accepted: Poster
    • A NEW ERA: HOW SOCIAL MEDIA CONTENT SURROUNDING “ANTI MULLERIAN HORMONE” HAS CHANGED OVER TIME
      Jenna Reich, MD , Nirali Jain, BA, MD and Jennifer K Blakemore, MD, MSc , (1)NYU Grossman School of Medicine, New York, NY, (2)NYU Langone Prelude Fertility Center, New York, NY
      Accepted: Poster
    • DO CANCER HEREDITARY SUSCEPTIBILITY SYNDROME (CHSS) CARRIERS HAVE ALTERED MARKERS OF OVARIAN RESERVE?
      Jenna Reich, MD, Nirali Jain, BA, MD, Alison Pruzan, MD, Mary Elizabeth Fino, M.D., David H McCulloh, PhD and Jennifer K Blakemore, MD, MSc, (1)NYU Grossman School of Medicine, New York, NY, (2)NYU Langone Prelude Fertility Center, New York, NY
      Accepted: Oral
    • IS TRANSABDOMINAL (TA) IMAGING AN ADEQUATE ALTERNATIVE TO TRANSVAGINAL (TV) IMAGING IN ART CYCLES?
      Skyler Finning, MD1, Nirali Jain, BA, MD2, Mary Elizabeth Fino, M.D.2, David H McCulloh, PhD2 and Jennifer K Blakemore, MD, MSc2, (1)NYU Grossman School of Medicine, New York, NY, (2)NYU Langone Prelude Fertility Center, New York, NY
      Accepted: Poster
    • TRENDS IN FROZEN EMBRYO TRANSFERS (FET) UTILIZATION AND OUTCOMES IN CANCER PATIENTS WHO UNDERWENT FERTILITY PRESERVATION (FP) BEFORE (PRE) AND AFTER (POST) CHEMOTHERAPY
      Alison Pruzan, MD, Nirali Jain, BA, MD, Jenna Reich, MD, Mary Elizabeth Fino, M.D., David H McCulloh, PhD and Jennifer K Blakemore, MD, MSc, (1)NYU Langone Health Fertility Center, New York, NY, (2)NYU Langone Prelude Fertility Center, New York, NY, (3)NYU Langone Fertility Center,New York, NY, (4)NYU Langone Health, New York, NY
    • DOES BRCA 1/2 CARRIER STATUS EFFECT OOCYTE CRYOPRESERVATION OUTCOMES?
      Nirali Jain, BA, MD1, Jenna Reich, MD2, Alison Pruzan, MD2, Mary Elizabeth Fino, MD1, David H McCulloh, PhD1 and Jennifer K Blakemore, MD, MSc1, (1)NYU Langone Fertility Center, New York, NY, (2)NYU Grossman School of Medicine, New York, NY
      Accepted: Poster
    • COVID-19 VACCINATION AND ASSISTED REPRODUCTION OUTCOMES: A LITERATURE REVIEW AND META-ANALYSIS
      Chamani et al.
      Accepted: Oral
    • PROJECT CARING – COMMUNICATING ABOUT REPRODUCTION AND INHERITED GENES: OUTCOMES OF A PILOT INTERVENTION FOR COUPLES WITH INHERITED CANCER RISK
      Dean, Baker, Reblin, Hintz, Haskins, Vadaparampil, Blakemore, Quinn
      Accepted: Poster
    • HOW MANY EGGS DO I NEED? NUMBER OF OOCYTES REQUIRED TO CREATE ONE EUPLOID BLASTOCYST USING FRESH RETRIEVALS OR FROZEN OOCYTES
      McCulloh et al.
      Accepted: Poster
    • SPECTRUM OF EMBRYO MOSAICISM DETECTED BY PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A) DETERMINES REPRODUCTIVE OUTCOME
      Besser et al.
      Accepted: Poster
    • CHARACTERIZATION OF EXTRACELLULAR VESICLES (EVs) IN HUMAN FOLLICULAR FLUID AND EMBRYO CULTURE MEDIA AND THE IMPACT ON ASSISTED REPRODUCTIVE TECHNOLOGY (ART) OUTCOMES
      Jacquelyn Shaw, MD; Angelica Ortiz, PhD; Peipei Wu, MS; Linda G. Kahn, PhD; Jennifer K. Blakemore, MD, MSc
      Accepted: Oral
    • DOES LUTEAL ESTRADIOL (E2) PRIMING IMPROVE EUPLOIDY RATES IN FREEZE-ALL PREIMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A) IN VITRO FERTILIZATION (IVF) CYCLES ACROSS SOCIETY FOR ASSISTED REPRODUCTIVE TECHNOLOGY (SART) AGE GROUPS?
      Jacquelyn Shaw, MD; James A. Grifo, MD, PhD; Jennifer K. Blakemore, MD MSc
      Accepted: Poster
    • FRAGILE X CARRIERS: IS THERE EXPANSION IN UTILIZATION OF PREIMPLANTATION GENETIC TESTING FOR MONOGENIC DISORDERS (PGT-M)?
      Jacquelyn Shaw, MD; Andria Besser, MS, CGC; James A. Grifo, MD, PhD; Jennifer K. Blakemore, MD MSc
      Accepted: Poster
    • SIMULATION IN REPRODUCTIVE ENDOCRINOLOGY AND INFERTILITY (REI): CLOSING THE COUNSELING GAP
      Jacquelyn Shaw, MD; Brielle Blatt, BS; Virginia Drda, BS; Sondra Zabar, MD; Frederick Licciardi, MD

      Accepted: Oral
    • EXPERIENCES AND INTENTIONS OF PATIENTS WHO UNDERWENT MEDICALLY INDICATED OOCYTE AND EMBRYO CRYOPRESERVATION: A QUALITATIVE STUDY
      Bayefsky, Sampson, Blakemore, Quinn
      Accepted: Oral
    • VITRIFICATION WITH DIMETHYL SULFOXIDE (DMSO) CRYOPROTECTANT ALTERS GENE AND TRANSPOSABLE ELEMENT (TE) EXPRESSION IN HUMAN OOCYTES
      Wiltshire, Schaal, Wang, Tou, Wilson, Keefe
      Accepted: Poster
    • DON’T BE TRIGGER SHY: A LOW SERUM LUTEINIZING HORMONE (LH) RESPONSE TO GONADOTROPIN-RELEASING HORMONE AGONIST (GnRH-A) HITS THE MARK IN PREMPLANTATION GENETIC TESTING FOR ANEUPLOIDY (PGT-A)
      Wiltshire, Tozour, Hamer, McCulloh, Grifo, Blakemore
      Accepted: Poster
    • SPERM DONOR AVAILABILITY AND SELECTION BASED ON RACE AND ETHNICITY
      Moreta, Simpson, Ghidei, Wiltshire
      Accepted: Poster